nefiracetam has been researched along with Depression in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, K; Han, F; Lu, YM; Nakano, T; Shioda, N; Yamamoto, Y | 1 |
| Clarence-Smith, K; Jorge, RE; Robinson, RG | 1 |
1 trial(s) available for nefiracetam and Depression
| Article | Year |
|---|---|
Double-blind randomized treatment of poststroke depression using nefiracetam.
Topics: Aged; Aged, 80 and over; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Mental Status Schedule; Middle Aged; Neurologic Examination; Psychotropic Drugs; Pyrrolidinones; Retrospective Studies; Stroke; Time Factors | 2008 |
1 other study(ies) available for nefiracetam and Depression
| Article | Year |
|---|---|
Improvement of depressive behaviors by nefiracetam is associated with activation of CaM kinases in olfactory bulbectomized mice.
Topics: Amygdala; Analysis of Variance; Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 1; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Depression; Hippocampus; Immunoblotting; Injections, Intraperitoneal; Male; Maze Learning; Memory; Mice; Mice, Inbred Strains; Nootropic Agents; Olfactory Bulb; Phosphorylation; Pyrrolidinones; Stress, Physiological; Swimming | 2009 |